Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy

Jonathan Saúl Bautista-Martínez, José Antonio Mata-Marín, Jorge Luis Sandoval-Ramírez, Alberto Chaparro-Sánchez, Bulmaro Manjarrez-Téllez, Luis Antonio Uribe-Noguez, Jesús Gaytán-Martínez, Mireya Núñez-Armendáriz, Arcenio Cruz-Sánchez, Nohemí Núñez-Rodríguez, Martínez Abarca Iván, Georgina Selene Morales-González, Juan Pablo Álvarez-Mendoza, Edgar Pérez-Barragán, Jussara Ríos-De Los Ríos, Gerson Gabriel Contreras-Chávez, Denisse Marielle Tapia-Magallanes, Rosa Maria Ribas-Aparicio, Mónica Díaz-López, Azucena Olivares-LabastidaAlejandro Gómez-Delgado, Javier Torres, Antonio Miranda-Duarte, Juan C. Zenteno, Ericka Nelly Pompa-Mera

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences